about
Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjectsStructure, function, and biology of the Enterococcus faecalis cytolysinAntibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistanceGeneration of dipeptidyl peptidase-IV-inhibiting peptides from β-lactoglobulin secreted by Lactococcus lactisDevelopment of Streptococcus pneumoniae Vaccines Using Live VectorsA liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.The phosphoenolpyruvate:sugar phosphotransferase system is involved in sensitivity to the glucosylated bacteriocin sublancin.Bacterial Evasion of Host Antimicrobial Peptide DefensesDatabase-Guided Discovery of Potent Peptides to Combat HIV-1 or SuperbugsEnergy metabolism and drug efflux in Mycobacterium tuberculosisChemical and Biological Aspects of Nutritional Immunity - Perspectives for New Anti-infectives Targeting Iron Uptake Systems.New Found Hope for Antibiotic Discovery: Lipid II Inhibitors.Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials.Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.In vitro synergistic activities of cefazolin and nisin A against mastitis pathogens.Contributions of the σ(W) , σ(M) and σ(X) regulons to the lantibiotic resistome of Bacillus subtilis.Comparative Genomics Revealed Genetic Diversity and Species/Strain-Level Differences in Carbohydrate Metabolism of Three Probiotic Bifidobacterial SpeciesAn association between peptidoglycan synthesis and organization of the Streptococcus pyogenes ExPortal.Synergistic Antibacterial Effect of the Combination of ε-Polylysine and Nisin against Enterococcus faecalis.ATPase activity regulation by leader peptide processing of ABC transporter maturation and secretion protein, NukT, for lantibiotic nukacin ISK-1.Bacteriocins as food preservatives: Challenges and emerging horizons.The Opp (AmiACDEF) Oligopeptide Transporter Mediates Resistance of Serotype 2 Streptococcus pneumoniae D39 to Killing by Chemokine CXCL10 and Other Antimicrobial Peptides.
P2860
Q21558804-0F4B29C9-98F1-47C5-9B1C-FBF3677CCFB8Q26823094-1FEDE8DA-1F3C-4928-9898-05A84E653292Q26991811-38D8C2E9-D4B1-45BB-BBFD-A133E9055BEAQ34064125-996EADC2-457C-4A30-A206-D2916D0D4D40Q34316015-4DDBDC16-2CAD-4838-985E-2287332BD646Q35473516-984E29DB-8492-4CC3-B903-38F8099F19CCQ36158307-7088E126-E76E-43A3-BD7D-9CBC7719BADBQ36720179-22D55368-BD50-42D3-8719-44977F6B10D8Q37277482-D3714FA6-E241-4816-975E-3774FCA251C9Q37712986-7E8A7391-C7F6-4A45-A6D8-51FE3A8AC377Q38691254-C1A4F78F-5949-49C1-99B5-89CAF32AE627Q38889355-D88D0CB9-1A9A-46E5-9FA2-69B1CB70B239Q38945513-1F04D808-0A44-4D56-9DB3-73B82D4FD690Q39109460-50CD0331-E680-45AF-938B-7442E5F6EDC8Q40113908-0C289250-B5E9-4C36-AA5A-9A4D9FE38F10Q41017751-73EE46C6-8B32-4D99-8EB9-B31DCD589091Q42355304-02B5EF13-A683-4AF3-8E61-79A49437485DQ42970061-B7C5450A-025B-4964-BCA5-030B1C1DB035Q46632606-DDA008BB-5023-4D1A-A858-8C330A81DAE0Q47371883-E064CFA4-CCC3-43E2-81A6-EF0101A8B32EQ48667972-3832582A-7931-4786-8C19-CA6B746317FDQ51148943-7BA50CAE-60E8-43B2-8ACC-4415A7A39CF1
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antimicrobial mechanism of lantibiotics.
@en
type
label
Antimicrobial mechanism of lantibiotics.
@en
prefLabel
Antimicrobial mechanism of lantibiotics.
@en
P2093
P2860
P356
P1476
Antimicrobial mechanism of lantibiotics.
@en
P2093
Jun-Ichi Nagao
Kenji Sonomoto
Mohammad R Islam
Takeshi Zendo
P2860
P304
P356
10.1042/BST20120190
P577
2012-12-01T00:00:00Z